- Home
- EVM vs ALMS Comparison
EVM vs ALMS Comparison
Compare EVM & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- ALMS
- Stock Information
- Founded
- EVM 2002
- ALMS 2021
- Country
- EVM United States
- ALMS United States
- Employees
- EVM N/A
- ALMS N/A
- Industry
- EVM Finance/Investors Services
- ALMS
- Sector
- EVM Finance
- ALMS
- Exchange
- EVM Nasdaq
- ALMS NYSE
- Market Cap
- EVM 230.9M
- ALMS 260.6M
- IPO Year
- EVM N/A
- ALMS 2024
- Fundamental
- Price
- EVM $9.29
- ALMS $5.64
- Analyst Decision
- EVM
- ALMS Strong Buy
- Analyst Count
- EVM 0
- ALMS 7
- Target Price
- EVM N/A
- ALMS $28.17
- AVG Volume (30 Days)
- EVM 55.8K
- ALMS 1.2M
- Earning Date
- EVM 01-01-0001
- ALMS 05-15-2025
- Dividend Yield
- EVM 4.01%
- ALMS N/A
- EPS Growth
- EVM N/A
- ALMS N/A
- EPS
- EVM 0.20
- ALMS N/A
- Revenue
- EVM N/A
- ALMS N/A
- Revenue This Year
- EVM N/A
- ALMS N/A
- Revenue Next Year
- EVM N/A
- ALMS N/A
- P/E Ratio
- EVM $47.61
- ALMS N/A
- Revenue Growth
- EVM N/A
- ALMS N/A
- 52 Week Low
- EVM $7.67
- ALMS $3.18
- 52 Week High
- EVM $9.59
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- EVM 42.71
- ALMS N/A
- Support Level
- EVM $9.32
- ALMS N/A
- Resistance Level
- EVM $9.52
- ALMS N/A
- Average True Range (ATR)
- EVM 0.08
- ALMS 0.00
- MACD
- EVM -0.01
- ALMS 0.00
- Stochastic Oscillator
- EVM 16.07
- ALMS 0.00
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.